183490 — Enzychem Lifesciences Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareAdventurousMicro Cap
- KR₩76bn
- -KR₩18bn
- KR₩68bn
Annual cashflow statement for Enzychem Lifesciences, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -27,865 | -25,093 | -9,403 | -22,088 | -18,092 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 8,496 | 10,804 | -3,846 | 9,811 | 5,227 |
| Unusual Items | |||||
| Purchased R&D | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -1,331 | -2,420 | -521 | 8,244 | -1,282 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -18,589 | -14,320 | -10,258 | -574 | -11,012 |
| Capital Expenditures | -5,883 | -8,013 | -2,302 | -489 | -779 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -3,846 | -101,220 | 55,864 | 7,848 | 12,706 |
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Sale of Intangible Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -9,729 | -109,233 | 53,562 | 7,359 | 11,927 |
| Financing Cash Flow Items | 0 | — | -0.555 | 0 | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 29,263 | 128,504 | -35,503 | -12,138 | -3,345 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 958 | 4,868 | 7,787 | -5,166 | -2,463 |